Capstone Investment Advisors’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-52,300
Closed -$1.97M 1248
2024
Q1
$1.97M Buy
+52,300
New +$1.97M 0.01% 325